A detailed history of Industrial Alliance Investment Management Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Industrial Alliance Investment Management Inc. holds 1,774 shares of VRTX stock, worth $831,509. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,774
Previous 1,709 3.8%
Holding current value
$831,509
Previous $695,000 6.76%
% of portfolio
0.31%
Previous 0.32%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $26,499 - $28,995
65 Added 3.8%
1,774 $742,000
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $122,451 - $146,612
-357 Reduced 17.28%
1,709 $695,000
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $461,953 - $495,120
1,366 Added 195.14%
2,066 $718,000
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $12.7 Million - $14.3 Million
-40,532 Reduced 98.3%
700 $246,000
Q1 2023

May 11, 2023

SELL
$283.23 - $323.1 $2.54 Million - $2.89 Million
-8,957 Reduced 17.85%
41,232 $13 Million
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $3.59 Million - $4.04 Million
-12,559 Reduced 20.01%
50,189 $14.5 Million
Q3 2022

Nov 18, 2022

BUY
$273.83 - $305.53 $3.67 Million - $4.1 Million
13,413 Added 27.19%
62,748 $18.2 Million
Q2 2022

Aug 10, 2022

BUY
$234.96 - $292.55 $1.49 Million - $1.85 Million
6,333 Added 14.73%
49,335 $13.9 Million
Q1 2022

May 13, 2022

SELL
$221.42 - $260.97 $1.03 Million - $1.21 Million
-4,630 Reduced 9.72%
43,002 $11.2 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $6.58 Million - $8.31 Million
37,172 Added 355.37%
47,632 $10.5 Million
Q4 2021

Feb 10, 2022

BUY
$177.01 - $223.45 $1.85 Million - $2.34 Million
10,460 New
10,460 $47.6 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Industrial Alliance Investment Management Inc. Portfolio

Follow Industrial Alliance Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Industrial Alliance Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Industrial Alliance Investment Management Inc. with notifications on news.